These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12759921)

  • 1. Genome-wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss.
    Simpson DJ; Bicknell EJ; Buch HN; Cutty SJ; Clayton RN; Farrell WE
    Genes Chromosomes Cancer; 2003 Jul; 37(3):225-36. PubMed ID: 12759921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas.
    Simpson DJ; Magnay J; Bicknell JE; Barkan AL; McNicol AM; Clayton RN; Farrell WE
    Cancer Res; 1999 Apr; 59(7):1562-6. PubMed ID: 10197629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of recurrence of nonfunctioning pituitary tumours by loss of heterozygosity analysis.
    Buch HN; Raskauskiene D; Bahar A; Bicknell EJ; Farrell WE; Clayton RN
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):19-25. PubMed ID: 15212640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele-specific loss of heterozygosity in multiple colorectal adenomas: toward an integrated molecular cytogenetic map II.
    Mao X; Hamoudi RA; Talbot IC; Baudis M
    Cancer Genet Cytogenet; 2006 May; 167(1):1-14. PubMed ID: 16682279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma.
    Langdon JA; Lamont JM; Scott DK; Dyer S; Prebble E; Bown N; Grundy RG; Ellison DW; Clifford SC
    Genes Chromosomes Cancer; 2006 Jan; 45(1):47-60. PubMed ID: 16149064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of pituitary tumors.
    Farrell WE; Clayton RN
    Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma.
    Wistuba II; Tang M; Maitra A; Alvarez H; Troncoso P; Pimentel F; Gazdar AF
    Cancer Res; 2001 May; 61(9):3795-800. PubMed ID: 11325854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas.
    Tahara H; Smith AP; Gas RD; Cryns VL; Arnold A
    Cancer Res; 1996 Feb; 56(3):599-605. PubMed ID: 8564978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
    Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
    Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
    Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN
    Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
    Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
    Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker.
    Bates AS; Farrell WE; Bicknell EJ; McNicol AM; Talbot AJ; Broome JC; Perrett CW; Thakker RV; Clayton RN
    J Clin Endocrinol Metab; 1997 Mar; 82(3):818-24. PubMed ID: 9062489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors.
    Mathew S; Murty VV; Bosl GJ; Chaganti RS
    Cancer Res; 1994 Dec; 54(23):6265-9. PubMed ID: 7954476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
    Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
    Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins.
    Clayton RN; Pfeifer M; Atkinson AB; Belchetz P; Wass JA; Kyrodimou E; Vanderpump M; Simpson D; Bicknell J; Farrell WE
    Clin Cancer Res; 2000 Oct; 6(10):3973-82. PubMed ID: 11051246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the MEN1 gene in sporadic pituitary adenomas.
    Schmidt MC; Henke RT; Stangl AP; Meyer-Puttlitz B; Stoffel-Wagner B; Schramm J; von Deimling A
    J Pathol; 1999 Jun; 188(2):168-73. PubMed ID: 10398160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.